SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000059478-24-000127
Filing Date
2024-05-09
Accepted
2024-05-09 16:34:08
Documents
14
Period of Report
2024-05-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K lly-20240506.htm   iXBRL 8-K 74865
  Complete submission text file 0000059478-24-000127.txt   300671

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20240506.xsd EX-101.SCH 4605
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20240506_def.xml EX-101.DEF 20143
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20240506_lab.xml EX-101.LAB 39023
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20240506_pre.xml EX-101.PRE 21422
17 EXTRACTED XBRL INSTANCE DOCUMENT lly-20240506_htm.xml XML 10543
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 24931328
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)